TGFB1 and renal fibrosis: Therapeutic approaches based on inhibiting TGF-β/Smad signaling have been reported to reduce renal injury and fibrosis in several pathological models, whereas overexpressing TGF- β1 induces renal fibrosis [6,8,11].